The use of prescription testosterone treatments such as AndroGel may be associated with the formation of venous blood clots, including pulmonary embolism and deep vein thrombosis. In 2014, the labels of all low-T therapy medications were updated with a general warning regarding a risk of venous blood clots.
Thousands of testosterone lawsuits have been filed on behalf of men who allegedly suffered serious cardiovascular complications, including deep vein thrombosis and pulmonary embolism. If you would like to learn more about filing a testosterone blood clot lawsuit, please call (888) 994-5118 to contact an attorney from the nationwide law firm of Bernstein Liebhard LLP.
The use of low-T therapy has been associated with a number of side effects that may increase a man’s risk for blood clots, including:
Testosterone blood clots may include:
Blood clots can also lead to a number of serious health consequences, including:
The labels for all testosterone treatments have long included a warning regarding venous blood clots related to polycythemia, an abnormal increase in the number of red blood cells that sometimes occurs with use of the drugs. However, in June 2014, the FDA required manufacturers to include a general warning in the drug labeling of all approved testosterone products about the risk of venous thromboembolism, venous blood clots that include deep vein thrombosis and pulmonary embolism. Read More
There is still time for the alleged victims of testosterone-related blood clots to file their own lawsuits against the manufacturers of low-T therapies. To learn more about this growing litigation, please contact our attorneys today, by calling (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.